vix.ing · top · new · best · stats

Betablokátory v léčbě kardiovaskulárních onemocnění

1998/03/01 by B. Max Jones, Michael Davison, Ivan Řiháček +2 · 2 citations
Agricultural and Biological Sciences · Mathematics · Medicine · Neuroscience · Psychology · #Animal Nutrition and Physiology #Artificial intelligence #Autism Spectrum Disorder Research #Behavioral and Psychological Studies #Cardiovascular and exercise physiology #Cardiovascular, Neuropeptides, and Oxidative Stress Research #Cognitive psychology #Computer science #Discrimination learning #Discriminative model #Heart Rate Variability and Autonomic Control #Mathematics #Medicine #Neuroscience #Psychology #Reinforcement #Schedule #Social psychology #Statistics #Stimulus control

paper · pdf · doi:10.1901/jeab.1998.69-161

published in Medicína pro praxi 2(2), 58-61 (Q12055306)

crossref issued 1998/03/01 · crossref published 1998/03/01 · crossref published-print 1998/03/01 · openalex publication_date 2006/01/01 · crossref created 2006/03/02 · crossref published-online 2013/02/26 · openalex created_date 2016/06/24 · crossref deposited 2023/10/28 · openalex updated_date 2026/06/11 · crossref indexed 2026/07/31

Abstract

Prvni klinicky použivaný betablokator propranolol byl syntetizovan již v roce 1964. Podle typu vazby na specificke receptory dělime moderni betablokatory na selektivni, neselektivni, s vnitřni sympatomimetickou aktivitou a s vazodilatacnim ucinkem. Jsou indikovany zejmena k lecbě pacientů s kardiovaskularnimi chorobami, u kterých prokazatelně snižuji nemocnost a umrtnost.

Citations

Cited by